Onyx Healthcare (ROCO:6569) Cyclically Adjusted Revenue per Share: NT$44.74 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6569 Onyx Healthcare Inc ROCO:6569
77 GF Score
Price NT$97.20
GF Value NT$129.36
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Onyx Healthcare Cyclically Adjusted Revenue per Share?

Onyx Healthcare ROCO:6569 +2.10% 77 Cyclically Adjusted Revenue per Share is NT$44.74 as of Mar. 2026. GuruFocus rates ROCO:6569 with a GF Score™ of 77/100 and a GF Value™ of NT$129.36 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Onyx Healthcare's adjusted revenue per share for the three months ended in Mar. 2026 was NT$9.635. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$44.74 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-01), Onyx Healthcare's current stock price is NT$97.20. Onyx Healthcare's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was NT$44.74. Onyx Healthcare's Cyclically Adjusted PS Ratio of today is 2.17.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Onyx Healthcare was 4.07. The lowest was 2.08. And the median was 2.57.


Onyx Healthcare  (ROCO:6569) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Onyx Healthcare's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=97.20/44.74
=2.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Onyx Healthcare was 4.07. The lowest was 2.08. And the median was 2.57.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Onyx Healthcare Cyclically Adjusted Revenue per Share Related Terms


Onyx Healthcare Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Onyx Healthcare's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onyx Healthcare Cyclically Adjusted Revenue per Share Chart

Onyx Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 44.48 44.06

Onyx Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.73 44.91 44.95 44.06 44.74

ROCO:6569 vs VEEV, BTSG, HQY: Cyclically Adjusted Revenue per Share Comparison

For the Health Information Services subindustry, Onyx Healthcare's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Onyx Healthcare Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Onyx Healthcare's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Onyx Healthcare's Cyclically Adjusted PS Ratio falls into.


ROCO:6569
77GF Score
Onyx Healthcare Inc ROCO:6569
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onyx Healthcare Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Onyx Healthcare's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=9.635/330.2130*330.2130
=9.635

Current CPI (Mar. 2026) = 330.2130.

Onyx Healthcare Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 9.538 241.018 13.068
201609 8.313 241.428 11.370
201612 6.555 241.432 8.965
201703 8.142 243.801 11.028
201706 9.826 244.955 13.246
201709 9.081 246.819 12.149
201712 9.596 246.524 12.854
201803 9.456 249.554 12.512
201806 9.443 251.989 12.374
201809 10.065 252.439 13.166
201812 11.250 251.233 14.787
201903 10.820 254.202 14.055
201906 12.827 256.143 16.536
201909 8.034 256.759 10.332
201912 10.170 256.974 13.069
202003 7.136 258.115 9.129
202006 10.424 257.797 13.352
202009 8.291 260.280 10.519
202012 12.180 260.474 15.441
202103 7.729 264.877 9.635
202106 7.229 271.696 8.786
202109 7.101 274.310 8.548
202112 12.885 278.802 15.261
202203 12.047 287.504 13.837
202206 9.361 296.311 10.432
202209 8.730 296.808 9.713
202212 12.617 296.797 14.038
202303 8.534 301.836 9.336
202306 9.308 305.109 10.074
202309 9.585 307.789 10.283
202312 11.128 306.746 11.979
202403 7.079 312.332 7.484
202406 7.697 314.175 8.090
202409 7.315 315.301 7.661
202412 9.795 315.605 10.248
202503 7.972 319.799 8.232
202506 9.176 322.561 9.394
202509 8.430 324.800 8.570
202512 8.019 324.054 8.171
202603 9.635 330.213 9.635

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of NT$44.74 mean?
Onyx Healthcare (ROCO:6569) has a Cyclically Adjusted Revenue per Share of NT$44.74 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Onyx Healthcare and its competitors.
Is Onyx Healthcare's Cyclically Adjusted Revenue per Share too high?
Onyx Healthcare's current Cyclically Adjusted Revenue per Share is NT$44.74. Overall, Onyx Healthcare has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Onyx Healthcare's Cyclically Adjusted Revenue per Share compare to VEEV and BTSG?
Onyx Healthcare's Cyclically Adjusted Revenue per Share of NT$44.74 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Onyx Healthcare and its competitors. Onyx Healthcare's current Cyclically Adjusted Revenue per Share is NT$44.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Onyx Healthcare (ROCO:6569) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$129.36, compared to a current price of NT$97.20 — trading 24.9% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is NT$44.74. Onyx Healthcare's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Onyx Healthcare (ROCO:6569), the current Cyclically Adjusted Revenue per Share is NT$44.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?

Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued. The current stock price of NT$97.20 is trading 24.9% below its estimated GF Value™ of NT$129.36. GuruFocus considers Onyx Healthcare to be Modestly Undervalued.

Key valuation signals for ROCO:6569:

  • Cyclically Adjusted Revenue per Share: NT$44.74
  • GF Value™: NT$129.36 vs. price of NT$97.20 (24.9% below fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Onyx Healthcare Business Description

Address No. 135, Lane 235, Baoqiao Road, 4th Floor, Xindian District, New Taipei, TWN, 231028
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
77GF Score

Get the complete analysis for ROCO:6569

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$97.20
Price
NT$129.36
GF Value